View in EDS HTML Full Text PDF Full Text

Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer.
Authors: Hummelink, Karlijn1,2 (AUTHOR) k.monkhorst@nki.nl, van der Noort, Vincent3 (AUTHOR), Muller, Mirte2 (AUTHOR), Schouten, Robert D.2 (AUTHOR), van den Heuvel, Michel M.2 (AUTHOR), Thommen, Daniela S.4 (AUTHOR), Smit, Egbert F.2 (AUTHOR), Meijer, Gerrit A.1 (AUTHOR), Monkhorst, Kim1 (AUTHOR) k.monkhorst@nki.nl
Source: PLoS ONE. 7/31/2024, Vol. 19 Issue 7, p1-21. 21p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19326203
DOI:10.1371/journal.pone.0293707